Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice

E Nessim Kostandy, JH Suh, X Tian, B Okeugo… - …, 2024 - digitalscholar.lsuhsc.edu
The probiotic Limosilactobacillus reuteri DSM 17938 produces anti-inflammatory effects in
scurfy (SF) mice, a model characterized by immune dysregulation, polyendocrinopathy …
[PDF] researchgate.net

[PDF][PDF] Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice. Nutrients 2024, 16, 511

E Nessim Kostandy, JH Suh, X Tian, B Okeugo… - 2024 - researchgate.net
The probiotic Limosilactobacillus reuteri DSM 17938 produces anti-inflammatory effects in
scurfy (SF) mice, a model characterized by immune dysregulation, polyendocrinopathy …

Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice.

E Nessim Kostandy, JH Suh, X Tian, B Okeugo… - …, 2024 - search.ebscohost.com
The probiotic Limosilactobacillus reuteri DSM 17938 produces anti-inflammatory effects in
scurfy (SF) mice, a model characterized by immune dysregulation, polyendocrinopathy …

Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice

EN Kostandy, JH Suh, X Tian, B Okeugo… - …, 2024 - pubmed.ncbi.nlm.nih.gov
The probiotic Limosilactobacillus reuteri DSM 17938 produces anti-inflammatory effects in
scurfy (SF) mice, a model characterized by immune dysregulation, polyendocrinopathy …
[HTML] nih.gov

[HTML][HTML] Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice

EN Kostandy, JH Suh, X Tian, B Okeugo, E Rubin… - Nutrients, 2024 - ncbi.nlm.nih.gov
The probiotic Limosilactobacillus reuteri DSM 17938 produces anti-inflammatory effects in
scurfy (SF) mice, a model characterized by immune dysregulation, polyendocrinopathy …

Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice

N Kostandy, J Suh, X Tian, B Okeugo, E Rubin, S Shirai… - Nutrients, 2024 - europepmc.org
The probiotic Limosilactobacillus reuteri DSM 17938 produces anti-inflammatory effects in
scurfy (SF) mice, a model characterized by immune dysregulation, polyendocrinopathy …

Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice.

N Kostandy, JH Suh, X Tian, B Okeugo, E Rubin… - Nutrients, 2024 - europepmc.org
The probiotic Limosilactobacillus reuteri DSM 17938 produces anti-inflammatory effects in
scurfy (SF) mice, a model characterized by immune dysregulation, polyendocrinopathy …

[引用][C] Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice.

N Kostandy, JH Suh, X Tian, B Okeugo, E Rubin…